Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LDL-C”

288 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 288 results

Post-approval studies (Phase 4)Study completedNCT00916643
What this trial is testing

Low-Density Lipoprotein (LDL) Apheresis Using H.E.L.P. Therapy

Who this might be right for
Familial Hypercholesterolemia
B. Braun Medical Inc. 113
Not applicableStudy completedNCT00536965
What this trial is testing

Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets

Who this might be right for
HyperlipidemiasAtherosclerosisCoronary Heart Disease+3 more
AstraZeneca 951
Early research (Phase 1)Study completedNCT02314442
What this trial is testing

An Investigational Drug, ALN-PCSSC, in Subjects With Elevated Low Density Lipoprotein Cholesterol (LDL-C)

Who this might be right for
Hypercholesterolemia
Alnylam Pharmaceuticals 70
Early research (Phase 1)Study completedNCT00055042
What this trial is testing

Laser and Antioxidant Treatment of Diabetic Macular Edema

Who this might be right for
Macular EdemaDiabetes Mellitus
National Eye Institute (NEI) 40
Large-scale testing (Phase 3)Active Not RecruitingNCT05739383
What this trial is testing

Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

Who this might be right for
Primary Prevention of Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 14,012
Testing effectiveness (Phase 2)Study completedNCT01652703
What this trial is testing

Evaluate Tolerability and Efficacy of Evolocumab (AMG 145) in Japanese Subjects

Who this might be right for
Hypercholesterolemia and High Risk for Cardiovascular Events
Amgen 310
Testing effectiveness (Phase 2)Study completedNCT04992065
What this trial is testing

A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart Disease

Who this might be right for
Atherosclerotic Cardiovascular Disease
Novo Nordisk A/S 267
Testing effectiveness (Phase 2)Looking for participantsNCT07307989
What this trial is testing

Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis

Who this might be right for
Ischemic StrokeHypercholesteremia
Chang Gung Memorial Hospital 300
Not applicableUnknownNCT05043740
What this trial is testing

PCSK9 Inhibitor on ACS Patients With Multivessel Disease and Relatively Low LDL-C Level in Chinese Population

Who this might be right for
Acute Coronary Syndrome
Second Xiangya Hospital of Central South University 1,360
Not applicableStudy completedNCT00299884
What this trial is testing

Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-lowering Strategy

Who this might be right for
DyslipidemiaVascular Disease
Queen's University 45
Not applicableStudy completedNCT01384032
What this trial is testing

Study Into Genetic Influence on Cholesterol Response to Dietary Fat

Who this might be right for
Cardiovascular Diseases
University of Reading 88
Post-approval studies (Phase 4)Looking for participantsNCT06789432
What this trial is testing

Efficacy and Safety of Atorvastatin and Ezetimibe (10/10mg) Fixed Dose Combination Versus Atorvastatin (20mg) Monotherapy in Bangladeshi Population

Who this might be right for
Hyperlipidemia (E.G., Hypercholesterolemia)
Dr. Md. Alimur Reza 500
Post-approval studies (Phase 4)UnknownNCT04100434
What this trial is testing

Effect of Evolocumab Added to Moderate-Intensity Statin Therapy on LDL-C Lowering and Cardiovascular Adverse Events in Patients With Acute Coronary Syndrome

Who this might be right for
Acute Coronary SyndromeProprotein Convertase Subtilisin/Kexin Type 9 Inhibitor
Tianjin Chest Hospital 500
Testing effectiveness (Phase 2)Study completedNCT00810979
What this trial is testing

Comparison of SLx-4090 Combined With Statin Therapy Versus Statin Alone in Reducing LDL-C in Patients With Hyperlipidemia

Who this might be right for
Hyperlipidemia
Response Pharmaceuticals 133
Not applicableStudy completedNCT03130699
What this trial is testing

Dulce Digital-Me: An Adaptive mHealth Intervention for Underserved Hispanics With Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Scripps Whittier Diabetes Institute 310
Not applicableLooking for participantsNCT07415109
What this trial is testing

Improving LDL-C Levels Through Temporal Self-regulation Theory-based, Personality-tailored Health Messages

Who this might be right for
AdherencePreventive Health Services
National University Health System, Singapore 3,000
Large-scale testing (Phase 3)Looking for participantsNCT06597006
What this trial is testing

Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

Who this might be right for
Familial Hypercholesterolemia - Homozygous
Novartis Pharmaceuticals 9
Large-scale testing (Phase 3)Study completedNCT03814187
What this trial is testing

Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C

Who this might be right for
ASCVDElevated CholesterolHeterozygous Familial Hypercholesterolemia+1 more
Novartis Pharmaceuticals 3,275
Not applicableStudy completedNCT00536796
What this trial is testing

Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets

Who this might be right for
HyperlipidemiasAtherosclerosisCoronary Heart Disease+3 more
AstraZeneca 1,096
Large-scale testing (Phase 3)Active Not RecruitingNCT05360446
What this trial is testing

Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events

Who this might be right for
Coronary Artery Disease
Novartis Pharmaceuticals 608
Load More Results